EGFR and non-small cell lung carcinoma: The most frequent subtypes were classical sensitive exon21 L858R and exon19 del mutations, which occurred in 158/377 and 137/351 patients, and accounted for 90% (288/320) of all the activating EGFR mutations, which was similar to the prevalence in NSCLC.27